Actively Recruiting
Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
Led by Biogipuzkoa Health Research Institute · Updated on 2025-02-19
180
Participants Needed
3
Research Sites
129 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.
CONDITIONS
Official Title
Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- Histological confirmation of lymphoma diagnosis requiring chemotherapy
- Availability for 80-minute exercise sessions twice a week for 20 weeks
- Own a mobile phone to receive study communication and use a physical activity app
- Eastern Cooperative Oncology Group performance status (ECOG) score of 2 or less
- Life expectancy greater than 12 months
- Willingness and availability to participate throughout the study period
You will not qualify if you...
- Contraindication to moderate to high intensity exercise
- Significant medical disorders including chronic psychiatric illness, intellectual disability, musculoskeletal, cardiac, or pulmonary problems that limit exercise
- Other malignant tumors in the past five years except controlled skin cancer
- Any illness that could be worsened by exercise
- Plans to be away from the city for more than two weeks during the study
- Already physically active meeting WHO exercise recommendations
- Receiving only immunotherapy treatment
- Lymphoma involvement in the central nervous system
- Any significant medical history limiting ability to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Hospital Universitario Araba (HUA)
Vitoria - Gateiz, Araba, Spain, 01009
Not Yet Recruiting
2
Hospital Universitario Galdakao (HUG)
Galdakao, Bizkaia, Spain, 48960
Active, Not Recruiting
3
Hospital Universitario Donostia (HUD)
San Sebastián, Guipuzcoa, Spain, 20014
Actively Recruiting
Research Team
C
Clinical Research Platform - Health Research Institut Biogipuzkoa
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here